NFKB1 and arthritic joint disease: We have demonstrated that local small peptide-mediated NF-κB inhibition not only ameliorated established arthritis and reduced bone destruction in an animal model of RA, but also prevented pro-inflammatory cytokine production by human RA synovial biopsies.